SV Health Investors
Overview
SV Health Investors is a global private equity and venture capital investment platform. The firm specializes in diversified healthcare funds spanning all sectors and stages, including biotechnology, healthcare growth equity and medtech. The firm seeks to transform healthcare one investment at a time by supporting entrepreneurs who create and build breakthrough companies and treatments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cerevance | May 2026 | Series C | Co-investor |
| Serenza Therapeutics | May 2026 | Series A | Co-investor |
| EpiVax | Apr 2026 | M&A | Lead |
| Syneron Bio | Mar 2026 | Series B | Co-investor |
| Mestag Therapeutics | Mar 2026 | Early Funding | Co-investor |
Key People
Eugene Hill
Managing Partner
Gregory Madden
Managing Partner
Kate Bingham
Managing Partner
Nikola Trbovic
Managing Partner
Tom Flynn
Managing Partner
Ali Jazayeri
Operating Partner
Brett Haumann
Operating Partner
Luke Johnson
Operating Partner
Charles Large
Venture Partner
Forbes Huang
Venture Partner
Hamish Cameron
Venture Partner
Iain Kilty
Venture Partner
Kevin Pojasek
Venture Partner
Luke Devey
Venture Partner
Ravi Rao
Venture Partner
Ruth Mckernan
Venture Partner At SV Health Investors
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.